Pancreatic Cancer Research

ResearcherAnhui Medical UniversityNo recent work listed

Jiaojiao Su

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7981-9497; OpenAlex author ID A5090093745. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 3

  1. Exosomal miR-19a decreases insulin production by targeting Neurod1 in pancreatic cancer associated diabetes. Co-author DOI 10.1007/s11033-021-06980-z↗
  2. MicroRNA-148a Suppresses the Proliferation and Migration of Pancreatic Cancer Cells by Down-regulating ErbB3. Co-author DOI 10.1097/mpa.0000000000000677↗
  3. Pancreatic cancer-secreted miR-155 implicates in the conversion from normal fibroblasts to cancer-associated fibroblasts. First author DOI 10.1111/cas.12747↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Weiyan Yao · 3 shared papers, 2015–2022 · strength 0.30
  2. Wenjing Pang · 2 shared papers, 2015–2022 · strength 0.24
  3. Xin Dai · 2 shared papers, 2015–2022 · strength 0.24
  4. Lei Li · 1 shared paper, 2022 · strength 0.19
  5. Hui Feng · 2 shared papers, 2015–2016 · strength 0.12
  6. Hongwei Liang · 1 shared paper, 2016 · strength 0.07
  7. Yaozong Yuan · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.